Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jose M. Auge"'
Autor:
Rafael Molina, Xavier Filella, Aureli Torné, J.A. Lejarcegui, Laura Foj, Jaume Pahisa, Jose M. Escudero, Jose M. Auge
Publikováno v:
Tumour Biology
Scopus-Elsevier
Scopus-Elsevier
The aim of this study is to evaluate a new tumour marker, HE4, in comparison with CA 125 and the Risk of Ovarian Malignancy Algorithm (ROMA) in healthy women and in patients with benign and malignant gynaecological diseases. CA 125 and HE4 serum leve
Autor:
Xavier Filella, Jose M. Escudero, Martín Velasco, Montserrat Muñoz, Rafael Molina, G. Zanon, Blanca Farrús, Jaume Pahisa, Jose M. Auge
Publikováno v:
Tumor Biology. 31:171-180
Tumor markers were studied in the sera of 883 untreated patients with primary breast cancer diagnosed between 1989 and 2007. Abnormal human epidermal growth factor receptor 2 (HER-2)/neu levels (>15 ng/mL) were found in 9.5%, carcinoembryonic antigen
Autor:
Xavier Filella, Jose M. Auge, José Ramírez, Ramon M. Marrades, Jose M. Escudero, Emilio Carcereny, Nuria Viñolas, Rafael Molina
Publikováno v:
Tumor Biology. 29:371-380
Tumor marker serum levels were prospectively studied in 289 patients with suspected, but unconfirmed, lung cancer and in 513 patients with lung cancer [417 non-small cell lung cancer (NSCLC) patients and 96 small cell lung cancer (SCLC) patients]. In
Publikováno v:
Clinical Chemistry and Laboratory Medicine. 50
HER-2/neu, also known as c-erbB-2/neu, is an oncogene located in chromosome 17 which encodes HER-2/neu, a transmembrane protein belonging to the EGFR family. The external domain of this protein is released by the cell and can be studied in serum by i
Autor:
Carles Conill, Laura Visa, Jose M. Escudero, Salvador Navarro, Laureano Fernández-Cruz, Joana Ferrer, Víctor Molina, Jose M. Auge, Rafael Molina, Xavier Filella, Miguel Angel López-Boado
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 33(3)
CA 19.9 serum levels were prospectively determined in 573 patients admitted to hospital for suspicion of pancreatic cancer. The final diagnosis was 77 patients with no malignancy, 389 patients with pancreatic cancer, 37 neuroendocrine pancreatic canc
Autor:
Jose M. Auge, Andreas Schalhorn, Petra Stieber, Rudolph Hatz, Stefan Holdenrieder, Rafael Molina
Publikováno v:
Cancer biomarkers : section A of Disease markers. 6(3-4)
Differential diagnosis of suspicious lung masses is essential for the selection of the appropriate therapy strategy. While non-small cell lung cancer (NSCLC) in early stages and single lung metastases from other cancers mostly are resected by surgery
Autor:
Martín Velasco, Xavier Filella, Aureli Torné, Rafael Molina, G. Zanon, Pedro L. Fernández, Jose M. Escudero, Jose M. Auge, Montserrat Muñoz, Blanca Farrús, Jaume Pahisa
Publikováno v:
Clinical chemistry. 56(7)
Background: The utility of carcinoembryonic antigen (CEA) and carbohydrate antigen 15.3 (CA 15.3) as prognostic factors in primary breast cancer is unclear. Methods: We prospectively studied CEA and CA 15.3 in the sera of 2062 patients with untreated
Autor:
Rafael, Molina, Jose M, Auge, Xavier, Filella, Nuria, Viñolas, Julian, Alicarte, Jose M, Domingo, Antonio M, Ballesta
Publikováno v:
Anticancer research. 25(3A)
We studied the specificity and sensitivity of progastrin releasing peptide (ProGRP) in 37 healthy subjects and 195 patients with benign and 149 with malignant diseases other than lung cancer. Likewise, we compared the ProGRP with other tumor markers
Autor:
Rafael Molina, Nuria Viñolas, Xavier Filella, Jose M. Auge, Antonio M. Ballesta, Julian Alicarte
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 25(1-2)
The specificity and sensitivity of pro-gastrin-releasing peptide (ProGRP) was evaluated in 37 healthy subjects, 197 patients with benign diseases and 310 patients with malignant diseases of different origins. Abnormal ProGRP serum levels (50 pg/ml) w
Autor:
Markus W. Büchler, Raffi Bekeredjian, Dong-Qing Zhang, Jose M. Auge, Xavier Filella, J. Michael Mathis, Rafael Molina, José Ramírez, Jose M. Escudero, David B. Wang, Lija Yin, Angela Märten, Nuria Viñolas, Takafumi Nishimura, Emilio Carcereny, Ramon M. Marrades, Xiao-Lin Li, Yong-Yu Liu, Jan Schmidt, Jianxiong Bao, Jonathan D. Glass, Katrin Hoffmann, Qian-Jin Zhang, David S. Knight
Publikováno v:
Tumor Biology. 29:383-384